PRS4 COST OF TREATMENT AND REIMBURSEMENT OF HOSPITALIZED COMMUNITY-ACQUIRED PNEUMONIA WITH I.V. MOXIFLOXACIN COMPARED TO STANDARD ANTIBIOTIC TREAMENT IN GERMANY
Abstract
Authors
J De Zeeuw T Pfeil IM Thate-Waschke C Ernen D Daniel TT Bauer BM Schlosser R Rychlik